Peijia Medical Limited (FRA:4WO)

Market Cap	448.49M +52.0%
Revenue (ttm)	79.36M +29.0%
Net Income	-26.77M
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	94
Open	0.6550
Previous Close	0.6300
Day's Range	0.6550 - 0.6550
52-Week Range	0.4460 - 1.0100
Beta	n/a
RSI	45.93
Earnings Date	Mar 25, 2026

About Peijia Medical

Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People’s Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products include transcatheter aortic valve replacement (TAVR) systems, crosslinked dry-tissue and polymeric tri leaflet TAVR systems, transcatheter aortic valve s...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2012
• Employees: 1,035
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4WO

Financial Performance

In 2024, Peijia Medical's revenue was 615.48 million, an increase of 39.53% compared to the previous year's 441.13 million. Losses were -226.58 million, -42.28% less than in 2023.

Financial numbers in CNY